Sydney, New South Wales, Australia The fund was located in Australia. The main department of described VC is located in the Sydney.
The fund is generally included in less than 2 deals every year. The real fund results show that this VC is 47 percentage points more often commits exit comparing to other companies. The important activity for fund was in 2005. The usual things for fund are deals in the range of 1 - 5 millions dollars. Opposing the other organizations, this Nanyang Ventures works on 71 percentage points more the average amount of lead investments. The higher amount of exits for fund were in 2008.
The overall number of key employees were 1.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - Australia. Among the most popular fund investment industries, there are Health Care, Information Technology. Among the most popular portfolio startups of the fund, we may highlight Catapult Genetics, TGR BioSciences, QRxPharma. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
The standard case for the fund is to invest in rounds with 2 partakers. Despite the Nanyang Ventures, startups are often financed by Kestrel Capital. The meaningful sponsors for the fund in investment in the same round are Uniseed Ventures, Spring Ridge Ventures, Innovation Capital. In the next rounds fund is usually obtained by Plymouth Growth Partners.
Related Funds
| Fund Name | Location |
| 500 Kobe | - |
| Collab Capital | Atlanta, Georgia, United States |
| CPC & Partners | Canada, Ontario, Toronto |
| Kateeva | California, Newark, United States |
| Korea Venture Capital Association (KVCA) | Seoul, Seoul-t'ukpyolsi, South Korea |
| Linear Capital Partners | California, Los Angeles, United States |
| Nanabianca | Florence, Italy, Toscana |
| Neev Fund | India, Maharashtra, Mumbai |
| NFX Ventures | - |
| Pays de la Loire Participations | France, Nantes, Pays de la Loire |
| Rukam Capital Trust | Kyonggi-do, Seongnam, South Korea |
| Spotify | Stockholm, Stockholm County, Sweden |
| Success Group | China, Foshan, Guangdong |
| Sylebra Capital | - |
| Tairui Investment | - |
| The Melohn Group | - |
| Transference Fund | China, Shanghai |
| University of Pittsburgh Innovation Institute | Pennsylvania, Pittsburgh, United States |
| Xinghao Venture Management Center | - |
| Xinyuan Investment | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
QRxPharma | $10M | 10 Dec 2002 | Sydney, New South Wales, Australia |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
QRxPharma | $10M | 10 Dec 2002 | Sydney, New South Wales, Australia |
